Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Neuraxis (NRXS) EPS (Weighted Average and Diluted) (2022 - 2025)

Neuraxis' EPS (Weighted Average and Diluted) history spans 4 years, with the latest figure at -$0.22 for Q3 2025.

  • For Q3 2025, EPS (Weighted Average and Diluted) rose 21.43% year-over-year to -$0.22; the TTM value through Sep 2025 reached -$0.99, down 32.0%, while the annual FY2024 figure was -$1.22, 72.89% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q3 2025 was -$0.22 at Neuraxis, up from -$0.23 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.27 in Q4 2023 and bottomed at -$2.38 in Q3 2023.
  • The 4-year median for EPS (Weighted Average and Diluted) is -$0.32 (2024), against an average of -$0.59.
  • The largest annual shift saw EPS (Weighted Average and Diluted) soared 485.71% in 2023 before it plummeted 177.78% in 2024.
  • A 4-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.07 in 2022, then skyrocketed by 485.71% to $0.27 in 2023, then plummeted by 177.78% to -$0.21 in 2024, then decreased by 4.76% to -$0.22 in 2025.
  • Per Business Quant, the three most recent readings for NRXS's EPS (Weighted Average and Diluted) are -$0.22 (Q3 2025), -$0.23 (Q2 2025), and -$0.33 (Q1 2025).